Serial changes of hemostasis in aneurysmal subarachnoid hemorrhage with special reference to delayed ischemic neurological deficits

View More View Less
  • 1 Department of Neurosurgery, Brain Research Institute, Niigata University, Niigata, Japan; and Department of Neurosurgery, Kuwana Hospital, Niigata, Japan
Restricted access

Purchase Now

USD  $45.00

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $505.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $600.00
Print or Print + Online

✓ This study was undertaken to elucidate comprehensively the serial changes occurring in hemostatic systems after aneurysmal subarachnoid hemorrhage (SAH) and thereby to ascertain whether the examination of the integrity of these systems is helpful in predicting delayed ischemic neurological deficits (DINDs). The authors examined 117 patients admitted to the hospital within 24 hours after onset of SAH. Blood samples were collected from each patient on Days 0 (at admission), 3, 6, 14, and 30. A number of hemostatic parameters were examined in these samples, and the relationships between their changes and DINDs were assessed. Eighteen (15.4%) of the patients exhibited DINDs, and their frequency increased as the severity of subarachnoid clotting increased. Also, the frequency of DINDs was significantly higher in the patients with hydrocephalus on initial computerized tomography (CT) scans than in those without hydrocephalus. Regarding the hemostatic parameters at admission, there was no significant difference between the patients with and without DINDs. On Day 3, however, the fibrinogen and D-dimer levels were higher in the patients with than in those without DINDs. The fibrinogen and thrombin—antithrombin complex levels on Day 6 and the D-dimer level on Day 14 in the patients with DINDs were higher than the corresponding levels in those without DINDs. Multivariate analyses revealed that the following variables (in order of importance) were independent predictors of DINDs: the levels of D-dimer on Day 3, fibrinogen on Day 6, and the presence of hydrocephalus on admission. These data indicate that the levels of hemostatic parameters in concert with the CT findings may enable us to predict the appearance of DINDs.

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $505.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $600.00

Contributor Notes

Address reprint requests to: Yukihiko Fujii, M.D., Department of Neurosurgery, Brain Research Institute, Niigata University, Asahimachi 1, Niigata, 951 Japan.
  • 1.

    Adams HP Jr, , Kassell NF, & Torner JC, et al: Predicting cerebral ischemia after aneurysmal subarachnoid hemorrhage: influences of clinical condition, CT results, and antifibrinolytic therapy. A report of the Cooperative Aneurysm Study. Neurology 37:15861591, 1987 Adams HP Jr, Kassell NF, Torner JC, et al: Predicting cerebral ischemia after aneurysmal subarachnoid hemorrhage: influences of clinical condition, CT results, and antifibrinolytic therapy. A report of the Cooperative Aneurysm Study. Neurology 37:1586–1591, 1987

    • Search Google Scholar
    • Export Citation
  • 2.

    Ameriso SF, , Wong VLY, & Ishii H, et al: Hematogenous factors and prediction of delayed ischemic deficit after subarachnoid hemorrhage. Stroke 23:14041409, 1992 Ameriso SF, Wong VLY, Ishii H, et al: Hematogenous factors and prediction of delayed ischemic deficit after subarachnoid hemorrhage. Stroke 23:1404–1409, 1992

    • Search Google Scholar
    • Export Citation
  • 3.

    Armitage P: Statistical Methods in Medical Research. London: Blackwell Scientific, 1971 Armitage P: Statistical Methods in Medical Research. London: Blackwell Scientific, 1971

    • Search Google Scholar
    • Export Citation
  • 4.

    Auer LM: Acute operation and preventive nimodipine improve outcome in patients with ruptured cerebral aneurysms. Neurosurgery 15:5766, 1984 Auer LM: Acute operation and preventive nimodipine improve outcome in patients with ruptured cerebral aneurysms. Neurosurgery 15:57–66, 1984

    • Search Google Scholar
    • Export Citation
  • 5.

    Beck DW, , Adams HP, & Flamm ES, et al: Combination of aminocaproic acid and nicardipine in treatment of aneurysmal subarachnoid hemorrhage. Stroke 19:6367, 1988 Beck DW, Adams HP, Flamm ES, et al: Combination of aminocaproic acid and nicardipine in treatment of aneurysmal subarachnoid hemorrhage. Stroke 19:63–67, 1988

    • Search Google Scholar
    • Export Citation
  • 6.

    Clouston JE, , Numaguchi Y, & Zoarski GH, et al: Intraarterial papaverine infusion for cerebral vasospasm after subarachnoid hemorrhage. AJNR 16:2738, 1995 Clouston JE, Numaguchi Y, Zoarski GH, et al: Intraarterial papaverine infusion for cerebral vasospasm after subarachnoid hemorrhage. AJNR 16:27–38, 1995

    • Search Google Scholar
    • Export Citation
  • 7.

    Fisher CM, , Kistler JP, & Davis JM: Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 6:19, 1980 Fisher CM, Kistler JP, Davis JM: Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 6:1–9, 1980

    • Search Google Scholar
    • Export Citation
  • 8.

    Fisher M, , Giannotta S, & Meiselman HJ: Hemorheological alterations in patients with subarachnoid hemorrhage. Clin Hemorheol 7:611618, 1987 Fisher M, Giannotta S, Meiselman HJ: Hemorheological alterations in patients with subarachnoid hemorrhage. Clin Hemorheol 7:611–618, 1987

    • Search Google Scholar
    • Export Citation
  • 9.

    Fishman SJ, , Wylonis LJ, & Glickman JD, et al: Cyclosporin A augments human platelet sensitivity to aggregating agents by increasing fibrinogen receptor availability. J Surg Res 51:9398, 1991 Fishman SJ, Wylonis LJ, Glickman JD, et al: Cyclosporin A augments human platelet sensitivity to aggregating agents by increasing fibrinogen receptor availability. J Surg Res 51:93–98, 1991

    • Search Google Scholar
    • Export Citation
  • 10.

    Fletcher AP, , Alkjaersig N, & Davies A, et al: Blood coagulation and plasma fibrinolytic enzyme system pathophysiology in stroke. Stroke 7:337348, 1976 Fletcher AP, Alkjaersig N, Davies A, et al: Blood coagulation and plasma fibrinolytic enzyme system pathophysiology in stroke. Stroke 7:337–348, 1976

    • Search Google Scholar
    • Export Citation
  • 11.

    Fujii Y, , Takeuchi S, & Sasaki O, et al: Hemostasis in spontaneous subarachnoid hemorrhage. Neurosurgery 37:226234, 1995 Fujii Y, Takeuchi S, Sasaki O, et al: Hemostasis in spontaneous subarachnoid hemorrhage. Neurosurgery 37:226–234, 1995

    • Search Google Scholar
    • Export Citation
  • 12.

    Fujii Y, , Takeuchi S, & Sasaki O, et al: Ultra-early rebleeding in spontaneous subarachnoid hemorrhage. J Neurosurg 84:3542, 1996 Fujii Y, Takeuchi S, Sasaki O, et al: Ultra-early rebleeding in spontaneous subarachnoid hemorrhage. J Neurosurg 84:35–42, 1996

    • Search Google Scholar
    • Export Citation
  • 13.

    Fujii Y, , Tanaka R, & Takeuchi S, et al: Hematoma enlargement in spontaneous intracerebral hemorrhage. J Neurosurg 80:5157, 1994 Fujii Y, Tanaka R, Takeuchi S, et al: Hematoma enlargement in spontaneous intracerebral hemorrhage. J Neurosurg 80:51–57, 1994

    • Search Google Scholar
    • Export Citation
  • 14.

    Fujii Y, , Tanaka R, & Takeuchi S, et al: Serial changes in hemostasis after intracranial surgery. Neurosurgery 35:2633, 1994 Fujii Y, Tanaka R, Takeuchi S, et al: Serial changes in hemostasis after intracranial surgery. Neurosurgery 35:26–33, 1994

    • Search Google Scholar
    • Export Citation
  • 15.

    Harris RJ, , Branston NM, & Symon L, et al: The effects of a calcium antagonist, nimodipine, upon physiological responses of the cerebral vasculature and its possible influence upon focal cerebral ischaemia. Stroke 13:759766, 1982 Harris RJ, Branston NM, Symon L, et al: The effects of a calcium antagonist, nimodipine, upon physiological responses of the cerebral vasculature and its possible influence upon focal cerebral ischaemia. Stroke 13:759–766, 1982

    • Search Google Scholar
    • Export Citation
  • 16.

    Hasegawa T, , Watanabe H, & Ishii S: Studies of intravascular components in cerebral vasospasm following subarachnoid hemorrhage. Neurosurg Rev 3:93100, 1980 Hasegawa T, Watanabe H, Ishii S: Studies of intravascular components in cerebral vasospasm following subarachnoid hemorrhage. Neurosurg Rev 3:93–100, 1980

    • Search Google Scholar
    • Export Citation
  • 17.

    Hijdra A, , van Gijn J, & Nagelkerke NJD, et al: Prediction of delayed cerebral ischemia, rebleeding, and outcome after aneurysmal subarachnoid hemorrhage. Stroke 19:12501256, 1988 Hijdra A, van Gijn J, Nagelkerke NJD, et al: Prediction of delayed cerebral ischemia, rebleeding, and outcome after aneurysmal subarachnoid hemorrhage. Stroke 19:1250–1256, 1988

    • Search Google Scholar
    • Export Citation
  • 18.

    Hunt WE, & Hess RM: Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg 28:1420, 1968 Hunt WE, Hess RM: Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg 28:14–20, 1968

    • Search Google Scholar
    • Export Citation
  • 19.

    Inagawa T, , Yamamoto M, & Kamiya K: Effect of clot removal on cerebral vasospasm. J Neurosurg 72:224230, 1990 Inagawa T, Yamamoto M, Kamiya K: Effect of clot removal on cerebral vasospasm. J Neurosurg 72:224–230, 1990

    • Search Google Scholar
    • Export Citation
  • 20.

    Jennett B, & Bond M: Assessment of outcome after severe brain damage. A practical scale. Lancet 1:480484, 1975 Jennett B, Bond M: Assessment of outcome after severe brain damage. A practical scale. Lancet 1:480–484, 1975

    • Search Google Scholar
    • Export Citation
  • 21.

    Juvela S, , Hillbom M, & Kaste M: Platelet thromboxane release and delayed cerebral ischemia in patients with subarachnoid hemorrhage. J Neurosurg 74:386392, 1991 Juvela S, Hillbom M, Kaste M: Platelet thromboxane release and delayed cerebral ischemia in patients with subarachnoid hemorrhage. J Neurosurg 74:386–392, 1991

    • Search Google Scholar
    • Export Citation
  • 22.

    Juvela S, , Öhman J, & Servo A, et al: Angiographic vasospasm and release of platelet thromboxane after subarachnoid hemorrhage. Stroke 22:451455, 1991 Juvela S, Öhman J, Servo A, et al: Angiographic vasospasm and release of platelet thromboxane after subarachnoid hemorrhage. Stroke 22:451–455, 1991

    • Search Google Scholar
    • Export Citation
  • 23.

    Kannel WB, , Wolf PA, & Castelli WP, et al: Fibrinogen and risk of cardiovascular disease: The Framingham Study. JAMA 258:11831186, 1987 Kannel WB, Wolf PA, Castelli WP, et al: Fibrinogen and risk of cardiovascular disease: The Framingham Study. JAMA 258:1183–1186, 1987

    • Search Google Scholar
    • Export Citation
  • 24.

    Kassell NF, & Drake CG: Timing of aneurysm surgery. Neurosurgery 10:514519, 1982 Kassell NF, Drake CG: Timing of aneurysm surgery. Neurosurgery 10:514–519, 1982

    • Search Google Scholar
    • Export Citation
  • 25.

    Kassell NF, , Peerless SJ, & Durward QJ, et al: Treatment of ischemic deficits from vasospasm with intravascular volume expansion and induced arterial hypertension. Neurosurgery 11:337343, 1982 Kassell NF, Peerless SJ, Durward QJ, et al: Treatment of ischemic deficits from vasospasm with intravascular volume expansion and induced arterial hypertension. Neurosurgery 11:337–343, 1982

    • Search Google Scholar
    • Export Citation
  • 26.

    Kasuya H, & Shimizu T: Activated complement components C3a and C4a in cerebrospinal fluid and plasma following subarachnoid hemorrhage. J Neurosurg 71:741746, 1989 Kasuya H, Shimizu T: Activated complement components C3a and C4a in cerebrospinal fluid and plasma following subarachnoid hemorrhage. J Neurosurg 71:741–746, 1989

    • Search Google Scholar
    • Export Citation
  • 27.

    Kasuya H, , Shimizu T, & Okada T, et al: Activation of the coagulation system in the subarachnoid space after subarachnoid haemorrhage: serial measurement of fibrinopeptide A and bradykinin of cerebrospinal fluid and plasma in patients with subarachnoid haemorrhage. Acta Neurochir 91:120125, 1988 Kasuya H, Shimizu T, Okada T, et al: Activation of the coagulation system in the subarachnoid space after subarachnoid haemorrhage: serial measurement of fibrinopeptide A and bradykinin of cerebrospinal fluid and plasma in patients with subarachnoid haemorrhage. Acta Neurochir 91:120–125, 1988

    • Search Google Scholar
    • Export Citation
  • 28.

    le Roux PD, , Newell DW, & Eskridge J, et al: Severe symptomatic vasospasm: the role of immediate postoperative angioplasty. J Neurosurg 80:224229, 1994 le Roux PD, Newell DW, Eskridge J, et al: Severe symptomatic vasospasm: the role of immediate postoperative angioplasty. J Neurosurg 80:224–229, 1994

    • Search Google Scholar
    • Export Citation
  • 29.

    Mizoi K, , Yoshimoto T, & Takahashi A, et al: Prospective study on the prevention of cerebral vasospasm by intrathecal fibrinolytic therapy with tissue-type plasminogen activator. J Neurosurg 78:430437, 1993 Mizoi K, Yoshimoto T, Takahashi A, et al: Prospective study on the prevention of cerebral vasospasm by intrathecal fibrinolytic therapy with tissue-type plasminogen activator. J Neurosurg 78:430–437, 1993

    • Search Google Scholar
    • Export Citation
  • 30.

    Ohkuma H, , Suzuki S, & Kimura M, et al: Role of platelet function in symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke 22:854859, 1991 Ohkuma H, Suzuki S, Kimura M, et al: Role of platelet function in symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke 22:854–859, 1991

    • Search Google Scholar
    • Export Citation
  • 31.

    Ryan LM: Efficiency of age-adjusted tests in animal carcinogenicity experiments. Biometrics 41:525531, 1985 Ryan LM: Efficiency of age-adjusted tests in animal carcinogenicity experiments. Biometrics 41:525–531, 1985

    • Search Google Scholar
    • Export Citation
  • 32.

    Säveland H, , Ljunggren B, & Brandt L, et al: Delayed ischemic deterioration in patients with early aneurysmal operation and intravenous nimodipine. Neurosurgery 18:146150, 1986 Säveland H, Ljunggren B, Brandt L, et al: Delayed ischemic deterioration in patients with early aneurysmal operation and intravenous nimodipine. Neurosurgery 18:146–150, 1986

    • Search Google Scholar
    • Export Citation
  • 33.

    Shibahashi H, & Yamaura A: [Coagulation-fibrinolytic abnormality and symptomatic vasospasm in the acute stage of ruptured cerebral aneurysms—analysis of α2 PI, α2 PIC, FDP and D dimer.] No To Shinkei 43:239246, 1991 (Jpn) Shibahashi H, Yamaura A: [Coagulation-fibrinolytic abnormality and symptomatic vasospasm in the acute stage of ruptured cerebral aneurysms—analysis of α2 PI, α2 PIC, FDP and D dimer.] No To Shinkei 43:239–246, 1991 (Jpn)

    • Search Google Scholar
    • Export Citation
  • 34.

    Solomon RA, , Post KD, & McMurtry JG: Depression of circulating blood volume in patients after subarachnoid hemorrhage: implications for the management of symptomatic vasospasm. Neurosurgery 15:354361, 1984 Solomon RA, Post KD, McMurtry JG: Depression of circulating blood volume in patients after subarachnoid hemorrhage: implications for the management of symptomatic vasospasm. Neurosurgery 15:354–361, 1984

    • Search Google Scholar
    • Export Citation
  • 35.

    Spallone A, , Mariani G, & Rosa G: Disseminated intravascular coagulation as a complication of ruptured intracranial aneurysms. Report of two cases. J Neurosurg 59:142145, 1983 Spallone A, Mariani G, Rosa G: Disseminated intravascular coagulation as a complication of ruptured intracranial aneurysms. Report of two cases. J Neurosurg 59:142–145, 1983

    • Search Google Scholar
    • Export Citation
  • 36.

    Suzuki R, , Masaoka H, & Hirata Y, et al: The role of endothelin-1 in the origin of cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 77:96100, 1992 Suzuki R, Masaoka H, Hirata Y, et al: The role of endothelin-1 in the origin of cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 77:96–100, 1992

    • Search Google Scholar
    • Export Citation
  • 37.

    Suzuki S, , Nonogaki Y, & Ebina K, et al: Changes of plasma thromboxane level in subarachnoid haemorrhage. A study with 11-dehydro-TXB2 as measuring index. Acta Neurochir 113:166170, 1991 Suzuki S, Nonogaki Y, Ebina K, et al: Changes of plasma thromboxane level in subarachnoid haemorrhage. A study with 11-dehydro-TXB2 as measuring index. Acta Neurochir 113:166–170, 1991

    • Search Google Scholar
    • Export Citation
  • 38.

    Toyoda O, , Nakajima H, & Nukui H: Changes in coagulation and fibrinolysis and effects of ticlopidine and cisternal drainage in the acute phase following aneurysm rupture. Neurol Med Chir 30:670675, 1990 Toyoda O, Nakajima H, Nukui H: Changes in coagulation and fibrinolysis and effects of ticlopidine and cisternal drainage in the acute phase following aneurysm rupture. Neurol Med Chir 30:670–675, 1990

    • Search Google Scholar
    • Export Citation
  • 39.

    Zabramski JM, , Spetzler RF, & Lee KS, et al: Phase I trial of tissue plasminogen activator for the prevention of vasospasm in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 75:189196, 1991 Zabramski JM, Spetzler RF, Lee KS, et al: Phase I trial of tissue plasminogen activator for the prevention of vasospasm in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 75:189–196, 1991

    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 337 272 27
Full Text Views 131 2 1
PDF Downloads 61 2 1
EPUB Downloads 0 0 0